---
title: A2780CP Orthotopic Model - TD2 Precision Oncology
description: A2780CP is a cisplatin-resistant ovarian cancer cell line used for studying drug resistance mechanisms and exploring therapeutic interventions.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/a2780cp.png
---

×

 

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

# A2780CP Orthotopic Model

**Synonyms:** –

A2780CP is a cisplatin-resistant subline derived from A2780, a human ovarian cancer cell line. It represents a valuable model for studying drug resistance mechanisms in ovarian cancer and developing strategies to overcome treatment resistance. A2780CP exhibits resistance to cisplatin, a commonly used chemotherapeutic agent for ovarian cancer. Researchers utilize this cell line to investigate mechanisms underlying cisplatin resistance, explore alternative treatment options, and develop targeted therapies for resistant ovarian cancer.

## Model Details

**Cancer Type:** Ovarian Cancer  
**Model Name:** A2780CP  
**Mouse Strain:** NCr Nude  
**Treatment Data Available:** N/A

## A2780/CP Survival

![A2780CP Orthotopic Model](https://td2inc.com/hubfs/Assets/GraphsFigures/a2780cp.png)

Survival of IP disseminated A2780/CP in NCr Nude mice (n=5)

### Request Additional Syngeneic Model Data

## CONTACT US

## Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.

[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)

[![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en)

Office  
13208 E. Shea Blvd,   
Suite 100   
Scottsdale, AZ 85259

Phone  
(602) 358-8300

Connect with us

- <https://www.linkedin.com/company/translational-drug-development/>
- <https://twitter.com/TD2_Oncology>

![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png)

© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)